BeOne Medicines AG (BVMF:B1ME34)
Brazil · Delayed Price · Currency is BRL 67.22
0.00 (0.00%)
At close: Feb 26, 2026
BeOne Medicines AG Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 286.93 | -644.79 | -881.71 | -2,004 | -1,458 |
Depreciation & Amortization | 131.68 | 167.03 | 83.94 | 63.05 | 45.49 |
Other Amortization | 24.88 | 4.73 | 3.74 | 3.23 | 0.97 |
Asset Writedown & Restructuring Costs | -100.4 | -13.23 | -8.49 | -27.74 | -28.99 |
Loss (Gain) From Sale of Investments | 76.22 | 24.02 | 16.22 | 22 | -7.63 |
Stock-Based Compensation | 510.86 | 441.62 | 367.62 | 303.16 | 240.71 |
Other Operating Activities | 6.52 | 37.15 | -368.23 | 11.11 | 26.89 |
Change in Accounts Receivable | -164.95 | -329.44 | -188.31 | 304.11 | -423.02 |
Change in Inventory | -93.17 | -91.5 | -140.95 | -56.69 | -153.33 |
Change in Accounts Payable | 79.83 | 121.5 | 21.48 | -4.35 | 20.01 |
Change in Unearned Revenue | 1.29 | 0.63 | -255.59 | -151.82 | 407.7 |
Change in Other Net Operating Assets | 367.89 | 141.64 | 192.82 | 41.14 | 30.3 |
Operating Cash Flow | 1,128 | -140.63 | -1,157 | -1,497 | -1,299 |
Capital Expenditures | -185.84 | -492.66 | -561.9 | -325.43 | -262.94 |
Sale (Purchase) of Intangibles | -80.69 | -36.47 | -34.37 | -143.67 | -51.91 |
Investment in Securities | -8.39 | -16.35 | 658.34 | 1,548 | 955.51 |
Other Investing Activities | -1.24 | -2.86 | -2.08 | -1.49 | - |
Investing Cash Flow | -276.16 | -548.35 | 60 | 1,077 | 640.66 |
Short-Term Debt Issued | 233.68 | 868.27 | 661.53 | 313.77 | 406.45 |
Long-Term Debt Issued | 850.59 | 9.05 | 22.5 | 37.37 | 16.84 |
Total Debt Issued | 1,084 | 877.32 | 684.03 | 351.15 | 423.29 |
Short-Term Debt Repaid | -1,045 | -704.22 | -309.58 | -417.08 | -321.75 |
Long-Term Debt Repaid | -35.68 | -28.03 | -13.69 | - | - |
Total Debt Repaid | -1,080 | -732.25 | -323.27 | -417.08 | -321.75 |
Net Debt Issued (Repaid) | 3.8 | 145.08 | 360.77 | -65.94 | 101.53 |
Issuance of Common Stock | 196.28 | 45.37 | 55.71 | 46.96 | 3,535 |
Repurchase of Common Stock | -24.2 | - | - | - | - |
Other Financing Activities | 883.56 | 3 | - | - | - |
Financing Cash Flow | 1,059 | 193.45 | 416.48 | -18.97 | 3,637 |
Foreign Exchange Rate Adjustments | 60.02 | -51.71 | -8.08 | -69.38 | 14.04 |
Net Cash Flow | 1,971 | -547.24 | -689.05 | -507.85 | 2,993 |
Free Cash Flow | 941.74 | -633.29 | -1,719 | -1,822 | -1,562 |
Free Cash Flow Margin | 17.63% | -16.62% | -69.93% | -128.68% | -132.76% |
Free Cash Flow Per Share | 8.30 | -6.01 | -16.47 | -17.67 | -16.83 |
Cash Interest Paid | 52.45 | 51.18 | 19.75 | 25.17 | 29.97 |
Cash Income Tax Paid | 100.68 | 69.43 | 56 | 29.5 | 15.7 |
Levered Free Cash Flow | 727.12 | -370.91 | -1,274 | -943.69 | -1,204 |
Unlevered Free Cash Flow | 748.64 | -357.28 | -1,271 | -931.75 | -1,186 |
Change in Working Capital | 190.9 | -157.17 | -370.54 | 132.39 | -118.35 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.